<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment of severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) in Europe between 1970 and 1986 is reviewed </plain></SENT>
<SENT sid="1" pm="."><plain>487 patients received an HLA-identical BMT: results are encouraging and currently suggest a 65% survival </plain></SENT>
<SENT sid="2" pm="."><plain>However, many patients cannot be offered this procedure because of the absence of an appropriate donor </plain></SENT>
<SENT sid="3" pm="."><plain>Forty-five patients were given a non-HLA identical BMT: results are dependent on the degree of mismatch </plain></SENT>
<SENT sid="4" pm="."><plain>Immunosuppression (IS) was given to 509 patients: 50% of these survive </plain></SENT>
<SENT sid="5" pm="."><plain>Some mechanisms regulating in vitro hematopoiesis are discussed, together with their relevance in the treatment of SAA </plain></SENT>
</text></document>